Cyclacel pharmaceuticals announces closing of a change of control transaction and appointment of new executive leadership

Berkeley heights, n.j., feb. 27, 2025 (globe newswire) -- cyclacel pharmaceuticals, inc. ("cyclacel") (nasdaq: cycc, nasdaq: cyccp), a biopharmaceutical company that develops innovative cancer medicines, today announced a change in control and leadership on february 26, 2025.
CYCC Ratings Summary
CYCC Quant Ranking